葡萄牙精神活性药物使用与误用的疾病与死亡后果
该研究为回顾性多源数据库研究,评估葡萄牙精神活性药物使用与误用相关的死亡、急诊入院、严重中毒呼叫及严重不良反应报告风险,并分析合并酒精和非法药物的影响。结果显示合并物质使用、抗抑郁药及酒精/非法药物暴露与严重中毒和死亡贡献风险升高相关,误用致急诊入院更多涉及苯二氮䓬类/z类药物和抗抑郁药。
要点
- 合并物质暴露的严重中毒风险RR=1.12,死亡贡献风险RR=9.03。
- 抗抑郁药暴露的严重中毒风险RR=1.04,死亡贡献风险RR=3.20。
- 误用致急诊入院更多涉及苯二氮䓬类/z类药物(RR=2.40)。
核心结论
- 葡萄牙精神活性药物误用常与多物质使用并存,并与显著健康风险相关。
- 公共卫生策略应优先针对高风险药物组合和最常引发不良结局的治疗类别。
研究设计与样本
- 回顾性多源数据库研究,旨在评估精神活性药物使用与误用在葡萄牙的疾病和死亡后果。
- 估计精神活性药物相关死亡、急诊入院、严重中毒呼叫和严重药物不良反应报告的风险,包括与酒精和非法药物合用。
主要发现
- 多数涉及组合(n=5973;70.2%)、抗抑郁药(n=5441;67.1%)或任何处方阿片类(n=355;67.4%)的故意暴露导致严重中毒(即建议就医)。
- 涉及物质组合(RR=1.12;95%CI:1.10-1.14)、抗抑郁药(RR=1.04;95%CI:1.02-1.05)及酒精和/或非法药物(RR=1.18;95%CI:1.15-1.21)的暴露严重中毒风险更高。
- 在6737例精神活性药物相关死亡中,166例(2.5%)被识别为药物对致命结局有贡献。
- 涉及物质组合(RR=9.03;95%CI:3.71-21.94)、抗抑郁药(RR=3.20;95%CI:2.28-4.49)及酒精和/或非法药物(RR=1.88;95%CI:1.36-2.61)的病例死亡贡献风险更高。
- 因精神活性药物误用导致的急诊入院(n=5826)更可能涉及苯二氮䓬类/z类药物(RR=2.40;95%CI:2.30-2.51)或抗抑郁药(RR=1.86;95%CI:1.80-1.93)。
临床怎么用
- 临床应重点关注精神活性药物与酒精/非法药物或多药合用的高风险组合。
- 对使用苯二氮䓬类/z类药物或抗抑郁药的患者,应加强误用风险评估与预防。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To characterize the morbidity and mortality consequences of psychoactive medicines use and misuse in Portugal. METHODS: Retrospective multisource database study to estimate the risk of psychoactive medicine-related deaths, emergency department admissions, serious poisoning calls and serious adverse drug reaction reports, including combination with alcohol and illicit drugs. RESULTS: Most intentional exposures to psychoactive medicines involving combinations (n = 5973; 70.2%), antidepressants (n = 5441; 67.1%) or any prescription opioid (n = 355; 67.4%) resulted in serious poisonings (i.e., medical assistance advised). The risk of serious poisoning was higher for exposures involving substance combinations (relative risk [RR] = 1.12; confidence interval [95% CI): 1.10-1.14), antidepressants (RR = 1.04; 95% CI: 1.02-1.05) and alcohol and/or illicit drugs (RR = 1.18; 95% CI: 1.15-1.21). Among 6737 psychoactive medicine-related deaths, 166 (2.5%) were identified where the medicine contributed to the fatal outcome. The risk of contribution to death was higher in cases involving substance combinations (RR = 9.03; 95% CI: 3.71-21.94), antidepressants (RR = 3.20; 95% CI: 2.28-4.49), and alcohol and/or illicit drugs (RR = 1.88; 95% CI: 1.36-2.61). Emergency department admission caused by misuse of a psychoactive medicine (n = 5826) were more likely to involve benzodiazepines/z-drugs (RR = 2.40; 95% CI: 2.30-2.51) or antidepressants (RR = 1.86; 95% CI: 1.80-1.93). CONCLUSIONS: Psychoactive medicine misuse in Portugal frequently occurs alongside polysubstance use and is associated with substantial health risks. Public health strategies should prioritize addressing high-risk medicine combinations and therapeutic groups most often found to trigger negative outcomes. This may be achieved by targeted prevention efforts integrated into health system design.
引用
- Carmona Araújo A, Guerreiro JP, Bulhosa C, et al. Morbimortality consequences of use and misuse of psychoactive medicines in Portugal. Br J Clin Pharmacol. 2025. PMID: 40682497. doi:10.1002/bcp.70171
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。